These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1649967)

  • 1. Characterisation of a light chain loss variant of the BCL1 lymphoma.
    George AJ; Foreman RC; Stevenson FK
    Mol Immunol; 1991 Jul; 28(7):789-99. PubMed ID: 1649967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the immunoglobulin heavy chain locus on expression of the VK1GAC light chain.
    Fulton RJ; Davie JM
    J Immunol; 1984 Jul; 133(1):465-70. PubMed ID: 6427345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
    George AJ; Spellerberg MB; Stevenson FK
    J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
    Koganei S; Ito M; Yamamoto K; Matsumoto N
    Immunol Lett; 2005 May; 98(2):232-44. PubMed ID: 15860223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants.
    George AJ; McBride HM; Glennie MJ; Smith LJ; Stevenson FK
    Hybridoma; 1991 Apr; 10(2):219-27. PubMed ID: 1908435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light chain loss and reexpression leads to idiotype switch. Surrogate light chains are probably responsible for this process.
    Caspi Y; Taya M; Hollander N; Haimovich J
    Curr Top Microbiol Immunol; 1995; 194():179-86. PubMed ID: 7895491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-mu treatment suppresses immunoglobulin light-chain gene expression and Peyer's patch development.
    Woloschak GE; Krco CJ; Rodriguez M
    Mol Immunol; 1989 Apr; 26(4):351-8. PubMed ID: 2497338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic approach to idiotypic vaccination for B cell lymphoma.
    Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
    Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimate of the light chain repertoire size of fetal and adult BALB/cJ and CBA/J mice.
    LeJeune JM; Briles DE; Lawton AR; Kearney JF
    J Immunol; 1982 Aug; 129(2):673-7. PubMed ID: 6806379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of heavy and light chains in IgM polymerization.
    Bornemann KD; Brewer JW; Beck-Engeser GB; Corley RB; Haas IG; Jäck HM
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4912-6. PubMed ID: 7761423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to idiotype inhibit in vitro growth of human B-cell lymphomas.
    van Endert PM; Heilig B; Hämmerling GJ; Moldenhauer G
    Blood; 1992 Jan; 79(1):129-37. PubMed ID: 1728304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of IgM molecules in light-chain deficient variants of a B-cell tumor.
    Taya M; Rabinovich E; Haimovich J
    Immunol Lett; 1992 Jul; 33(2):173-7. PubMed ID: 1446924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant trafficking of the B cell receptor Ig-alpha beta subunit in a B lymphoma cell line.
    Condon C; Hourihane SL; Dang-Lawson M; Escribano J; Matsuuchi L
    J Immunol; 2000 Aug; 165(3):1427-37. PubMed ID: 10903747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotypic vaccination as a treatment for a B cell lymphoma.
    George AJ; Folkard SG; Hamblin TJ; Stevenson FK
    J Immunol; 1988 Sep; 141(6):2168-74. PubMed ID: 3049800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.
    Karasuyama H; Rolink A; Melchers F
    J Exp Med; 1993 Aug; 178(2):469-78. PubMed ID: 8340754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin alters the expression of different forms of immunoglobulin mu heavy chains and their associated proteins by pre-B cell lines and normal Ly-1 (CD5+) B cells.
    Chen J; Herzenberg LA; Herzenberg LA
    Int Immunol; 1991 Nov; 3(11):1117-27. PubMed ID: 1722112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of idiotypic vaccination in mice bearing B-cell lymphoma.
    Khan NA
    In Vivo; 1989; 3(2):117-9. PubMed ID: 2519837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the rearrangement of immunoglobulin genes, the appearance of a B lymphocyte antigen, and immunoglobulin synthesis in murine pre-B cell lines.
    Sugiyama H; Akira S; Yoshida N; Kishimoto S; Yamamura Y; Kincade P; Honjo T; Kishimoto T
    J Immunol; 1982 Jun; 128(6):2793-7. PubMed ID: 6281337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.